{"product_id":"acute-coronary-syndromes-9781405135016","title":"Acute Coronary Syndromes","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe management of non-ST segment elevation acute coronary syndromes (NSTE-ACS) has rapidly evolved over the last few years and many guidelines have been provided and already updated. This book is based on the latest ESC Guidelines and reports the current knowledge in NSTE-ACS, together with the most recent therapeutic options and the different strategies that can be applied according to the clinical status of patients.\u003cbr\u003e \u003cp\u003e\u003cbr\u003e \u003c\/p\u003e \u003cp\u003eInternational experts address the different aspects of NSTE-ACS and bring useful information to clinicians, interventionalists and surgeons involved in the difficult management of these patients.\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003eThe ESC Education Series\u003c\/b\u003e\u003cbr\u003e This book is part of the ESC Education Series. The series is designed to provide medical professionals with the latest information about the understanding, diagnosis and management of cardiovascular diseases. Where available, management recommendations are based on the established European Guidelines, wh\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003eList of contributors viii\u003c\/p\u003e \u003cp\u003ePreface x\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection one: Epidemiology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 1 Epidemiology of non-ST-segment elevation acute coronary syndromes 3\u003cbr\u003e\u003ci\u003eDavid Hasdai and Alexander Battler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection two: Pathophysiology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 2 Pathologic findings in acute coronary syndromes 11\u003cbr\u003e\u003ci\u003eErling Falk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 3 Vascular biology of acute coronary syndromes 24\u003cbr\u003e\u003ci\u003eLina Badimon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection three: Clinical aspects of ACS\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 4 Clinical aspects of acute coronary syndromes 43\u003cbr\u003e\u003ci\u003eEugene McFadden\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 5 Circulating biomarkers for risk stratification 52\u003cbr\u003e\u003ci\u003eChristopher Heeschen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection four: Investigation in ACS\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 6 Coronary angiography angioscopy and intravascular ultrasound in non-ST-segment elevation acute coronary syndromes 65\u003cbr\u003e\u003ci\u003eEric Van Belle Christophe Bauters François Schiele and Michel E. Bertrand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 7 New coronary imaging in acute coronary syndrome 78\u003cbr\u003e\u003ci\u003ePim J. de Feyter Evelyne Regar and Nico R.A. Mollet\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection five: Special groups of patients\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 8 Acute coronary syndromes in specialgroups of patients 97\u003cbr\u003e\u003ci\u003ePiero O. Bonetti Michael J. Zellweger Christoph Kaiser and Matthias E. Pfisterer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection six: Pharmacological treatment\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 9 Antiischemic treatment (nitrates β-blockers calcium antagonists) 109\u003cbr\u003e\u003ci\u003eDavid McCarty Colum G. Owens and A.A. Jennifer Adgey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 10 Antiplatelet therapies: aspirin thienopyridines and glycoprotein IIb\/IIIa receptor inhibitors 116\u003cbr\u003e\u003ci\u003eJaydeep Sarma and Keith A.A. Fox\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 11 Antithrombin drugs: LMWH unfractionated heparin direct thrombin inhibitors 139\u003cbr\u003e\u003ci\u003eRaphaelle Dumaine and Gilles Montalescot\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 12 Statin therapy in ACS 152\u003cbr\u003e\u003ci\u003eFrançois Schiele\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection seven: Myocardial revascularization\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 13 Percutaneous coronary interventions and stenting\/CABG in non-ST-segment elevation acute coronary syndromes 165\u003cbr\u003e\u003ci\u003eNicolas Meneveau and Jean-Pierre Bassand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection eight: Therapeutic strategy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 14 Risk stratification and therapeutic strategy 187\u003cbr\u003e\u003ci\u003eChristian W. Hamm\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 15 Indication for revascularization in non-ST-elevation acute coronary syndrome 199\u003cbr\u003e\u003ci\u003eLars Wallentin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 16 Management of patients with nonamenable lesions for myocardialrevascul arization 211\u003cbr\u003e\u003ci\u003eVictor Legrand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 17 Non-ST-segment elevation coronary syndromes: European Society of Cardiology guidelines 225\u003cbr\u003e\u003ci\u003eMichel E. Bertrand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 18 Non-ST-segment elevation acute coronary syndromes: ACC\/AHA guidelines 236\u003cbr\u003e\u003ci\u003ePierre Théroux\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 19 From guidelines to registries 248\u003cbr\u003e\u003ci\u003eLuigi Tavazzi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection nine: Secondary prevention\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 20 Secondary prevention after acute episode of patients presenting with nonpersistent ST-segment elevation 261\u003cbr\u003e\u003ci\u003eMichel E. Bertrand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 21 How to detect vulnerable plaque 270\u003cbr\u003e\u003ci\u003eDirk Boese and Raimund Erbel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 22 Localversus systemic prevention treatment 281\u003cbr\u003e\u003ci\u003eMario Togni and Bernhard Meier\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eConclusions 294\u003c\/p\u003e \u003cp\u003eIndex 295\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49407873286487,"sku":"9781405135016","price":90.86,"currency_code":"GBP","in_stock":false}],"url":"https:\/\/bookcurl.com\/products\/acute-coronary-syndromes-9781405135016","provider":"Book Curl","version":"1.0","type":"link"}